Table 4.
TGAb was a risk factor for eyelid erythema.
| Risk factor | Odds ratio (OR) |
95% confidence interval (95% CI) | P-value |
|---|---|---|---|
| Model 1 | |||
| TGAb | 1.064 | 1.017 – 1.114 | 0.008* |
| Model 2 | |||
| TGAb | 1.116 | 1.031 – 1.208 | 0.007* |
| Age (years) | 1.138 | 0.997 – 1.300 | 0.055 |
| Gender (f/m) | 0.854 | 0.063 – 11.592 | 0.906 |
| History of hyperthyroidism | 58.377 | 1.734 – 1964.804 | 0.023* |
| Antithyroid therapy (including drug and RAI therapy) | 0.074 | 0.005 – 1.014 | 0.051 |
| TED duration (months) | 1.000 | 0.979 – 1.022 | 0.978 |
| Smoker | 0.793 | 0.037 – 17.190 | 0.882 |
| Immunosuppressive therapy in the last 3 months | 2.755 | 0.229 – 33.075 | 0.424 |
Model 1 is a univariate logistic regression analysis with eyelid erythema as the dependent variable. Model 2 is a multivariate logistic regression analysis adjusted for age, gender, history of hyperthyroidism, antithyroid therapy (including drug and RAI therapy), TED duration, smoker, and immunosuppressive therapy in the last 3 months with eyelid erythema as the dependent variable. *P < 0.05.